Insider trading

Period: 120 months Stock: PHR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

437 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

437 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

437 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

437 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
437 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
437 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

437 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2021
Linetsky David SVP, Life Sciences
Sold, plan not stated 3×
$94.22K 1,578 at 59.71
1.7%
15 Mar 2021
Linetsky David SVP, Life Sciences
Sold, plan not stated 2×
$2.96M 48,482 at 61.15
34.0%
19 Feb 2021
Altier Thomas Chief Financial Officer
Sold, plan not stated 2×
$65.83K 904 at 72.83
1.1%
18 Feb 2021
Altier Thomas Chief Financial Officer
Sold, plan not stated 3×
$5.49M 76,272 at 71.96
48.3%
18 Feb 2021
CAHILL EDWARD L Director
Sold, plan not stated 3×
$720.03K 10,000 at 72.00
14.1%
29 Jan 2021
VanDuyn Amy Beth SVP, Human Resources
Sold, plan not stated 4×
$1.44M 21,829 at 65.91
29.6%
22 Jan 2021
Altier Thomas Chief Financial Officer
Sold, plan not stated 2×
$104.18K 1,495 at 69.69
0.9%
20 Jan 2021
Indig Chaim Chief Executive Officer
Sold, plan not stated 3×
$983.72K 14,892 at 66.06
1.3%
20 Jan 2021
Linetsky David SVP, Life Sciences
Sold, plan not stated 2×
$450.80K 6,826 at 66.04
4.6%
19 Jan 2021
Indig Chaim Chief Executive Officer
Sold, plan not stated 2×
$3.84M 59,986 at 63.95
5.1%
19 Jan 2021
Sold, plan not stated 2×
$2.24M 35,000 at 63.86
17.5%
19 Jan 2021
Roberts Evan Chief Operating Officer
Sold, plan not stated 2×
$351.30K 5,500 at 63.87
0.9%
19 Jan 2021
Linetsky David SVP, Life Sciences
Sold, plan not stated
$330.12K 5,136 at 64.28
3.3%
19 Jan 2021
Altier Thomas Chief Financial Officer
Sold, plan not stated
$301.08K 4,704 at 64.00
2.9%
15 Jan 2021
Indig Chaim Chief Executive Officer
Sold, plan not stated 3×
$4.72M 75,122 at 62.81
6.4%
5 Jan 2021
Roberts Evan Chief Operating Officer
Sold, plan not stated 2×
$1.15M 21,468 at 53.43
3.5%
4 Jan 2021
Roberts Evan Chief Operating Officer
Sold, plan not stated 4×
$4.21M 80,245 at 52.48
11.7%
4 Jan 2021
Sold, plan not stated 3×
$315.41K 6,000 at 52.57
49.5%
4 Jan 2021
VanDuyn Amy Beth SVP, Human Resources
Sold, plan not stated
$27.13K 500 at 54.26
1.1%
24 Dec 2020
CAHILL EDWARD L Director
Sold, plan not stated
$1.39M 24,370 at 57.22
25.6%
17 Dec 2020
Pegus Cheryl Director
Sold, plan not stated
$472.49K 8,415 at 56.15
33.4%
16 Dec 2020
Pegus Cheryl Director
Sold, plan not stated
$1.27M 22,732 at 55.83
47.4%
23 Oct 2020
Altier Thomas Chief Financial Officer
Sold, plan not stated
$331.21K 8,669 at 38.21
5.1%
22 Oct 2020
Altier Thomas Chief Financial Officer
Sold, plan not stated
$3.25M 86,237 at 37.65
35.0%
21 Oct 2020
VanDuyn Amy Beth SVP, Human Resources
Sold, plan not stated
$379.19K 10,834 at 35.00
17.6%
12 Oct 2020
Altier Thomas Chief Financial Officer
Sold, plan not stated
$217.78K 6,779 at 32.13
4.1%
1 Oct 2020
Roberts Evan Chief Operating Officer
Sold, plan not stated
$456.95K 14,774 at 30.93
2.1%
1 Oct 2020
Linetsky David SVP, Life Sciences
Sold, plan not stated 2×
$138.67K 4,477 at 30.97
3.4%
11 Sep 2020
Altier Thomas Chief Financial Officer
Sold, plan not stated 2×
$189.71K 6,779 at 27.99
5.6%
17 Aug 2020
Kallenbach Charles General Counsel & Secretary
Sold, plan not stated
$74.59K 2,500 at 29.84
6.0%
11 Aug 2020
Altier Thomas Chief Financial Officer
Sold, plan not stated 2×
$204.04K 6,779 at 30.10
5.6%
10 Aug 2020
Sold, plan not stated
$181.82K 6,000 at 30.30
49.5%
31 Jul 2020
Nathan Daniel Chief Technology Officer
Sold, plan not stated
$264.39K 8,804 at 30.03
13.5%
21 Jul 2020
CAHILL EDWARD L Director
Sold, plan not stated
$263.52K 9,080 at 29.02
16.3%
17 Jul 2020
Nathan Daniel Chief Technology Officer · indirect
Sold, plan not stated
$1.13M 38,683 at 29.25
82.9%
Sold half or more
17 Jul 2020
Kallenbach Charles General Counsel & Secretary
Sold, plan not stated
$73.23K 2,500 at 29.29
6.0%
1 Jul 2020
Roberts Evan Chief Operating Officer
Sold, plan not stated
$355.62K 12,500 at 28.45
1.8%
1 Jul 2020
Linetsky David SVP, Life Sciences
Sold, plan not stated
$126.40K 4,475 at 28.24
3.3%
17 Jun 2020
Kallenbach Charles General Counsel & Secretary
Sold, plan not stated
$73.15K 2,500 at 29.26
6.0%
12 Jun 2020
Munson Gillian Director
Sold, plan not stated
$141.60K 5,000 at 28.32
23.8%
18 May 2020
Kallenbach Charles General Counsel & Secretary
Sold, plan not stated
$68.00K 2,500 at 27.20
6.0%
7 May 2020
Linetsky David SVP, Life Sciences
Sold, plan not stated
$6.63K 255 at 26.00
0.2%
1 May 2020
VanDuyn Amy Beth SVP, Human Resources
Sold, plan not stated 2×
$335.19K 13,474 at 24.88
23.3%
1 May 2020
Altier Thomas Chief Financial Officer
Sold, plan not stated
$26.67K 1,096 at 24.34
0.9%
27 Apr 2020
Linetsky David SVP, Life Sciences
Sold, plan not stated
$109.72K 4,220 at 26.00
3.1%
23 Apr 2020
Kallenbach Charles General Counsel & Secretary
Sold, plan not stated
$125.00K 5,000 at 25.00
11.5%
9 Apr 2020
Davidoff Michael J. See Remarks
Sold, plan not stated
$86.14K 4,285 at 20.10
3.9%
1 Apr 2020
Davidoff Michael J. See Remarks
Sold, plan not stated
$28.26K 1,404 at 20.13
1.3%
30 Mar 2020
Davidoff Michael J. See Remarks
Sold, plan not stated
$13.78K 689 at 20.00
0.6%
26 Mar 2020
Davidoff Michael J. See Remarks
Sold, plan not stated
$77.26K 3,851 at 20.06
4.6%
Showing 351–400 of 437. ← Newer Page 8 of 9 Older →